What happens when pharma and flow cores face the same challenge — doing more with less?​ Join Ryan Duggan (AbbVie) and David ...
Before you embark on an uncertain AI journey, you need a set of clear objectives, a roadmap, and a cap on costs.
Validating AI is increasingly getting societal attention. AI safety has been a low priority. No more. I explore validation as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results